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Abstract
Background: Thioredoxin reductase (TR) is a redox active protein involved in many cellular
processes as part of the thioredoxin system. Presently there are three recognised forms of
mammalian thioredoxin reductase designated as TR1, TR3 and TGR, that represent the cytosolic,
mitochondrial and novel forms respectively. In this study we elucidated the genomic organisation
of the mouse (Txnrd1) and human thioredoxin reductase 1 genes (TXNRD1) through library
screening, restriction mapping and database mining.
Results: The human TXNRD1 gene spans 100 kb of genomic DNA organised into 16 exons and
the mouse Txnrd1 gene has a similar exon/intron arrangement. We also analysed the alternative
splicing patterns displayed by the mouse and human thioredoxin reductase 1 genes and mapped the
different mRNA isoforms with respect to genomic organisation. These isoforms differ at the 5' end
and encode putative proteins of different molecular mass. Genomic DNA sequences upstream of
mouse exon 1 were compared to the human promoter to identify conserved elements.
Conclusions:  The human and mouse thioredoxin reductase 1 gene organisation is highly
conserved and both genes exhibit alternative splicing at the 5' end. The mouse and human
promoters share some conserved sequences.
Background
The thioredoxin system is comprised of thioredoxin
(Trx) and thioredoxin reductase (TR) and plays an im-
portant role in maintaining the redox state of the cell [1].
This system is involved in many cellular functions in-
cluding synthesis of deoxyribonucleotides [2], redox
control of transcription factors [3], protection against
oxidative stress [4], cell growth and cancer [5]. The re-
duced form of Trx is maintained by TR, an enzyme that
contains a redox active disulphide group and a FAD mol-
ecule that uses the reducing power of NADPH [6,7].
Presently, there are three recognised forms of mammali-
an thioredoxin reductase: TR1, TR3 and TGR, that share
a similar domain organisation and all contain seleno-
cysteine [8–14]. TR1 was the first thioredoxin reductase
to be characterised and is known as the cytosolic form
[8]. TR3 is the mitochondrial form and is also known as
TrxR2 [9–11]. TGR, previously known as the novel form
of thioredoxin reductase (or TR2) functions as a Trx and
GSSG reductase [11,12]. In this study, we focus upon the
cytosolic form of mouse thioredoxin reductase (mTR1)
and human thioredoxin reductase (hTR1). The mouse
Txnrd1 gene is located on chromosome 10 and yields a
cDNA sequence approximately 3200 bp long. This se-
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quence encodes a protein with 499 amino acids and a
molecular mass of 54.5 kDa [15]. The human TXNRD1
gene is located on chromosome 12 [16] and the first
cDNA sequence reported was 3826 bp and encoded a
protein of 495 amino acids with a molecular mass of 54.1
kDa [8]. Recently it was reported that the mouse Txnrd1
gene is alternatively spliced, producing three isoforms of
mouse Txnrd1 mRNA that vary in their 5' sequences but
have common downstream sequences [17]. Also recently,
the human TXNRD1 gene has been reported to exhibit
possible alternative splicing around its first exon [18].
Here we report the genomic organisation of the human
and mouse thioredoxin reductase 1 genes, subsequently
detailing the alternative splicing pattern of the first exon
in both species. We also present a potential mouse
Txnrd1 promoter region and compare this genomic DNA
sequence with the recently studied TXNRD1 gene pro-
moter [18] to identify conserved sequences.
Results and Discussion
Mouse Txnrd1 genomic organisation
To determine the genomic structure of the mouse Txnrd1
gene we initially screened a mouse genomic DNA library
using a mouse Txnrd1 cDNA fragment as a probe. Suc-
cessful screening, restriction mapping and Southern blot
analysis revealed two overlapping Txnrd1 genomic
clones approximately 15 kb in length. One clone was ex-
tensively mapped and sequenced and aligned with the
Txnrd1 cDNA sequence [15] to reveal intron/exon junc-
tions. The genomic sequences contained exons 5, 6, 9, 10,
11, 12, 13, 14 and 15 (accession numbers AF394929,
AF394930, AF394931, AF394932, AF394933,
AF394934, AF394935, AF394936 and AF394937 re-
spectively). The location of exons 7 and 8 was deter-
mined by restriction enzyme mapping, however the
precise intron/exon junctions were established using
mouse genomic sequences from the National Centre for
Biotechnology Information (NCBI) Trace Archive
[www.ncbi.nlm.nih.gov] . Two sequences numbered
18222987 and 20784325 in the archive were used to con-
firm exons 7 and 8 respectively. These alignments ena-
bled the intron/exon boundaries to be fully mapped
between exons 5 and 15 (Table 1). Exons 5 to 15 span ap-
proximately 14 kb which is consistent with the size of the
mouse genomic Txnrd1 clone obtained from the library
screen. The intron/exon junctions for exons 1 to 4 and 16
were determined by database mining using genomic
Txnrd1 DNA sequences deposited in the Trace Archive of
the NCBI. Database searches using cDNA sequences cor-
responding to exons 1 to 4 and exon 16 [15] produced a
number of 1 kb sequences. The following mouse Txnrd1
genomic sequences 19029770, 19679815, 18378992,
22011035, 17424013 and 18272097 were used to deduce
intron/exon boundaries for exons 1, 2, 3a, 3b, 4 and 16
(respectively) although intron lengths could not be de-
termined. Table 1 shows the length of each exon ranging
from the shortest, exon 5 (73 bp), to the longest, exon 3b
(338 bp). The principal ATG start codon is located in
exon 4 and the TAA stop codon in exon 16. Another ATG
start codon that is utilised by one mRNA isoform gener-
ated by alternative gene splicing is found in exon 3b. Ta-
ble 1 also shows the intron lengths in the region spanning
exons 5 to 15. These sizes range from the shortest, intron
13 (94 bp), to the longest, intron 15 (3.13 kb). All introns
display splice signals consistent with the GT/AG rule
[19], except intron 4, in which the 5' splice donor is GC
instead of GT. This discrepancy in the 5' splice donor in
intron 4 is consistent with that also found in intron 4 of
the human TXNRD1 gene (Table 1).
Human TXNRD1 genomic organisation
To determine the genomic structure of the human
TXNRD1 gene, the human genome data from the NCBI
database  [www.ncbi.nlm.nih.gov]  was searched using
the TXNRD1 cDNA [8] sequence. Alignments were used
to establish intron/exon junctions, and these results con-
firmed through the adherence of predicted splice signals
to the AG/GT rule [19] and by comparisons made with
the mouse intron/exon junctions described above. The
cDNA sequences for mouse and human thioredoxin re-
ductase are approximately 80% homologous, and the hu-
man [20] and mouse [21] thioredoxin genes have an
identical genomic organisation. Therefore we predicted
that the human and mouse thioredoxin reductase genes
would also have a similar organisation. After searching
approximately 100 kb of human TXNRD1 genomic DNA
sequence, all exons were mapped.
The mapping of the human TXNRD1 gene is detailed in
Table 1. Exon lengths range from the shortest, exon 1a
(42 bp), to the longest, exon 3b (341 bp). The start codon
is located in exon 4, however another ATG is found in
exon 1 and may be utilised in at least one mRNA isoform
[18]. The stop codon is positioned in exon 16, as is the
3'UT region. Intron sizes vary greatly from the shortest,
intron 10 (917 bp), to the longest mapped intron, intron
12 (26.97 kb). Table 1 also lists the intron/exon splice sig-
nals which all conform to the AG/GT rule [19], except in-
tron 4. Like intron 4 in the mouse Txnrd1 gene, the
human 5' splice donor contains a GC instead of GT. The
occurrence of this splice signal deviation in both mouse
and human thioredoxin reductase intron 4 sequences is
interesting since the 5' region of both genes are involved
in alternative splicing and this could represent a poten-
tial regulatory site.
Alternative splicing of mouse and human TXNRD1 genes
Recent reports of alternative splicing in both the mouse
[17,22] and human [18] thioredoxin reductase genes leadBMC Genomics 2001, 2:10 http://www.biomedcentral.com/1471-2164/2/10
us to investigate the link between splicing events and ge-
nomic organisation. This investigation was carried out
through comparisons of mouse and human thioredoxin
reductase expressed sequence tags (EST) with the ge-
nomic organisation as described in this report.
Alternative splicing of mouse Txnrd1 gene
The Gladyshev group [17] proposed the first three exons
in the mouse Txnrd1 gene are alternatively spliced, pro-
ducing three isoforms of mouse Txnrd1 mRNA (Figure
1). These three mRNA isoforms were reported to contain
exons 1 and 4, 2 and 4, and 3 and 4 to generate isoforms
I, II and III respectively. Transcripts consistent with
some of these isoforms were described in another study
[22], although they were labelled differently.
• Isoform I
As reported by Sun et al [17], isoform I contains the ATG
start codon positioned within exon 4 and translation of
the resulting sequence produces the first reported mouse
TR1 protein of 54.5 kDa [15].
• Isoform II
With respect to isoform II, we noted that ESTs (for exam-
ple, accession number AI956288) containing exon 2 al-
ways displayed exon 1 immediately upstream, or did not
extend far enough to be informative. Thus isoform II ap-
pears to contain exons 1, 2, 4, 5, 6, 7 etc (Figure 1). The
only ATG start codon in the correct reading frame is lo-
cated in exon 4, hence translation of this isoform would
also yield the 54.5 kDa mouse TR1 protein [15].
• Isoform III
With respect to form III, ESTs containing exon 3 (acces-
sion numbers AA168412, AI607108) were aligned with
mouse Txnrd1 genomic DNA sequences in order to es-
tablish the intron/exon junctions. Alignment of a mouse
Txnrd1 EST containing exon 3 (accession number
AI607108) with mouse genomic Txnrd1 sequence (Trace
Archive 22011035) showed exon 3 is actually comprised
of two exons, designated as exons 3a and 3b in this study.
The splicing signals around exon 3b are consistent with
Table 1: Intron/Exon boundaries of human TXNRD1 and mouse Txnrd1 genes
Exon 
Number 
TXNRD1/
Txnrd1
Intron 
Numbera 
TXNRD1/
Txnrd 1
Human TXNRD1 Gene Mouse Txnrd1 Gene
Exon
size
(bp)
Intron
size
(kb)
Sequence at intron/EXON/intron 
junctionb
Exon 
size 
(bp)
Intron 
size 
(kb)
Sequence at intron/EXON/intron junctionb
1a 1 -- 4 2 - c t g c agTCCTGA--ATTCTTgtaagc 112 - ccggagCCACTA--GTTCAT gtaagc
1---2 7 9 - c t g c agTCCTGA--CATGTGgtaagt - -
2 2 1a 1 110 1.86 acacagAGGACG---TTGAAGgtagga 107 ND ccacagAGGGGG------CTGAAGgtagga
1- - 1 . 6 2
- 3a - 2a - - 115 ND gctaagGTTCAT-------ACTAAGgtaagg
3b 3b 2 2b 341 25.56 ccacagTGCTTT-----GGGCTGgtaagt 338 ND ccacag TGCCCT-----GAGCTGgtaagt
43 1 2 3 1 . 1 9 c t t t agGCTTAT-------GCTAAGgcaagg 123 ND ctgcagCCGAAC-------GCTAAGgcaaga
5 4 73 1.83 ttccagGAGGCA-----GATGGGgtaagc 73 ND tcccagGAGGCA-------GATGGGgtgagt
65 1 2 0 2 . 4 6 t t g t agGTCTTG-----AGACAGgtatga 120 1.62 ttgcagGTCTCG---------ACACAGgtgtgg
76 1 5 3 1 . 7 6 a t a c agTTAAGC-----ATTAAGgtaatt 143 1.4 acgcagTGAAGC-------ATTGTGgtaatt
8 7 116 0.414 tgttagGCAACA------CAGCAGgtaaag 116 0.411 ttgcagGCGACA--------CAGCAGgtgggt
9 8 226 1.51 ccccagTGATGA----ATTAAAgtaagt 226 1.59 ctccagTGATGA--------ACGAAAgtaagt
10 9 93 9.29 ttacagGTTGAA-----AATACGgtaagg 93 0.559 ttgtagATTGAA---------AACACAgtaagg
11 10 77 0.917 tttcagGTGATG------TGAAAAgtaaga 77 0.416 ttttagGTGTTG----------CGAAAAgtaagg
12 11 157 6.19 ttgcagGACTGG-----GTCAAGgtgagt 158 0.950 ttgcagAACCGG-------GTCAAAgtgaga
13 12 108 26.97 aaacagTGTGAC----ATTGAGgtaagt 109 0.094 acacagTGTGAC-------ATTGAAgtaagt
14 13 96 9.67 tcttagGTTTAC-------GACAATgtaagt 96 2.03 ttccagGTTTAC---------GACGATgtaagt
15 14 135 1.58 ccttagGAACGT-----GCAGAGgtgggt 135 3.126 tcttagGAACGT---------GCAGAGgtgagt
16 15 69 9.08 ctgcagGTATTC-----GGTTAA 3'UT 138 ND ctgcagATATTC--------GGTGAAgtgcNg
a Introns are numbered at 3' splice acceptor ie. intron 3 precedes exon 4. b Nucleotide sequences indicated at the intron (lowercase letters) and 
exon (uppercase letters) junctions.BMC Genomics 2001, 2:10 http://www.biomedcentral.com/1471-2164/2/10
the AG/GT rule [19]. Exon 3a was aligned with the mouse
genomic  Txnrd1 DNA sequence (Trace Archive
18378992) to confirm a consensus splice sequence at the
5' splice donor site to form the intron between exon 3a
and 3b. The 5' end of exon 3a could not be accurately de-
fined since the 5'end of isoform III has not been accu-
rately mapped. All ESTs containing exon 3 sequences
always contain both exon 3a and 3b and therefore iso-
form III is predicted to contain exons 3a, 3b, 4, 5, 6, 7 etc
(Figure 1). Two ATG start codons in the same reading
frame are present in exons 3b and 4. Translation from
the start codon encoded in exon 4 would produce the
original 54.5 kDa protein, however use of the start codon
in exon 3b yields a protein with a predicted molecular
mass of 67 kDa. This 67 kDa protein coincides with the
67 kDa mTR1 protein previously reported [17].
Alternative splicing of human TXNRD1 gene
Alternative splicing of the human TXNRD1 gene was in-
vestigated based on that already determined for the
mouse Txnrd1 gene and also on recent reports of possi-
ble alternative splicing in the human TXNRD1 gene
[17,18]. The Arner group [18] reported three isoforms of
human TXNRD1 mRNA – I, II and III, however these
isoforms do not align with the three mouse mRNA iso-
forms previously discussed. In this report the human
TXNRD1 isoforms are numbered according to structural
and sequence similarity displayed with the mouse
Txnrd1 isoforms where possible. Subsequently the iso-
forms I, II and III reported by the Arner group are denot-
ed here as isoforms V, II and I (respectively). In addition
to the isoforms reported by the Arner group we identified
two further isoforms (isoforms IV and VI) and proposed
another (isoform III), that would align with the mouse
isoform III.
• Isoform I
Isoform I contains exons 1, 2, 4, 5, 6, 7 etc (accession
number BF182740) [8] and represents the human
TXNRD1 cDNA sequence first reported [8]. There are
two ATG start codons in the correct reading frame in ex-
ons 1 and 4. The ATG in exon 4 directs translation of the
orginal 54.1 kDa hTR1 protein [8]. Translation of this
mRNA isoform from the ATG in exon 1 yields a protein
with a predicted molecular mass of approximately 60
kDa [18]. This protein coincides with a 60 kDa hTR1 pro-
tein previously reported [22].
• Isoform II
Isoform II is comprised of exons 1, 4, 5, 6, 7 etc (acces-
sion number AU077310). The ATG start codon is in exon
4 and directs translation of the original 54.1 kDa hTR1
protein.
• Isoform III
Isoform III is predicted to contain exons 3b, 4, 5, 6, 7 etc,
however no human thioredoxin reductase EST was
found to contain exon 3b. Therefore isoform III is not de-
noted in Figure 1. This isoform prediction was based on
sequence comparisons made between the mouse exon 3a
and 3b sequences with human genomic TXNRD1 se-
quences. A human TXNRD1 genomic region with homol-
ogy to mouse exon 3b was detected (Figure 2). This
alignment was flanked by canonical GT/AG splice sig-
nals at equivalent positions to that observed for mouse
exon 3b, indicating the possibility of the human TXNRD1
mRNA isoform III. Exon 3a was not identified in the hu-
man genome sequences possibly due to low homology
between the mouse and human 5' UT region. An align-
Figure 1
Exon 1 alternative splicing pattern in mouse and human
thioredoxin reductase 1 genes. The shaded area (A) shown
in TXNRD1 exon 1 is 42 bp in length and represents an alter-
native splicing site within the exon. The mRNA isoforms of
Txnrd1 and TXNRD1 are represented by: a green line for Iso-
form I; a red line for Isoform II; a blue line for Isoform III; a
purple line for Isoform IV; and a pink line for Isoform V. The
resulting mRNA isoforms are also shown with predicted
start codons indicated by the ∆  symbol.
1A 1 2 3b 4 5
A
Human TXNRD1
1 2 3a 3b 4
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ment between the deduced amino acid sequences de-
rived from the mouse and human exon 3b (Figure 3)
reveals a 50% identity between the two species (as out-
lined in Figure 3). If conservative amino acid substitu-
tions are taken into consideration the homology
percentage increases to approximately 70%. The high de-
gree of sequence conservation further substantiates the
likelihood of exon 3b being utilised in an as yet unde-
scribed human mRNA variant.
An analysis of the reading frame in exon 3b revealed
three in frame ATG codons that could potentially initiate
translation. Translation of this mRNA isoform from the
most 5' ATG start codon in exon 3b would produce a pro-
tein with a predicted molecular mass of approximately
67 kDa. A human TR1 protein with a mass of 67 kDa has
been detected [17] substantiating the possibility that
exon 3b is present in some mRNA transcripts. A search
of the EST and nucleotide databases failed to identify any
expressed sequences that contain exon 3b.
• Isoform IV
Isoform IV was discovered following an EST database
search. This isoform contains exon 1A, 4, 5, 6, 7 etc (ac-
cession number AU132293). Exon 1A is a product of an
internal splice site located within exon 1. This splice site
generates a 42 bp fragment that corresponds to the 5'
end of exon 1. There is one ATG start codon in the correct
reading frame in exon 4 and translation from this ATG
yields the original 54.1 kDa hTR1 protein [8].
• Isoforms V
This isoform contains exons 1A, 2, 4, 5, 6, 7 etc (accession
number BG771986). The ATG start codon is in exon 4
and directs translation to produce the original 54.1 kDa
human TR1 protein [8].
• Isoforms VI
Isoform VI was discovered via an EST database search.
This isoform contains exons 2, 4, 5, 6, 7 etc (accession
number BG772375) and the ATG codon is found in exon
4 where it directs translation to potentially produce the
original 54.1 kDa TR1 protein [8]. The EST that revealed
this isoform extends a further 300 bp immediately up-
stream of the 5' end of exon 2. The nature of this 300 bp
region is unknown as it did not display homology with
human TXNRD1 cDNA sequences or any sequence in
GenBank. Subsequently the 5' end of this isoform may
not terminate with exon 2.
Potential thioredoxin reductase regulatory elements
The alternative splicing pattern utilised by both the
TXNRD1 and Txnrd1 genes generate mRNA isoforms
that are heterogenous at the 5' end. This alternative
splicing presents consequences for possible gene regula-
tion and location of control elements. Indeed Rundlof
and co-workers [22] recently reported that the alterna-
Figure 2
Alignment of mouse thioredoxin reductase 1 (Txnrd1) exon
3b with partial human thioredoxin reductase 1 (TXNRD1)
genomic DNA sequence. Splice junctions (AG/GT) are out-
lined in TXNRD1. The ATG codon that yields the 67 kDa
protein form is conserved in both genes and is boxed.
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Figure 3
Alignment of human thioredoxin reductase (hTR1) exon 3b
deduced amino acid sequence with mouse thioredoxin
reductase (mTR1) exon 3b deduced amino acid sequence.
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tively spliced mouse transcripts are expressed in a tissue
specific manner. Currently the only genome information
regarding transcriptional control of thioredoxin reduct-
ase 1 genes is available in the recent identification and
characterisation of the core promoter for the human
TXNRD1 gene [18]. This core promoter of approximately
180 bp contains Oct 1, Sp1 and Sp3 binding sites and has
an increased GC content, suggesting the human
TXNRD1 gene is a house keeping gene. However this
does not explain the response of TXNRD1 to cellular sig-
nalling since thioredoxin reductase protein and mRNA
levels are known to increase quickly and significantly in
human cells in response to exogenous agents. It is possi-
ble that the core promoter for the human TXNRD1 gene
is accompanied by other promoter elements that have
not yet been identified. Comparisons between mouse
and human promoter regions may reveal these potential
regulatory elements.
A promoter region for the mouse Txnrd1 gene has yet to
be elucidated. However in this study a genomic sequence
of mouse DNA (NCBI Trace Archive 19029770) that ex-
tends 450 bp upstream from exon 1 has been examined
for possible control elements. This sequence, when
aligned with the human TXNRD1 core promoter region
[18] produced a nucleotide match of approximately 70%
(Figure 4). This potential mouse promoter region, like
the corresponding human region, lacks a classical TATA
box. Unlike the human region, it also lacks consensus
Sp1, Sp3 and Oct 1 binding sites at equivalent positions.
However it does contain potential AP-1 binding sites, one
of which is conserved in the human promoter. There is
also a potential CAAT box present at position 325 in both
the mouse and human sequences (Figure 4). Promoter
studies with the human promoter suggest this CAAT box
is not required as part of the core promoter [18].
The mouse Txnrd1 mRNA isoform III does not contain
exon 1, instead exon 3a is the most 5' exon. This infers
that a potential promoter region may be present just up-
stream from exon 3a. This isoform encodes a 67 kDa pro-
tein that is expressed at lower levels [17] than the 54.5
kDa mouse TR1 protein first identified [15]. The differ-
ence in expression levels of these two forms of mouse
Txnrd1 may be a reflection of the use of alternate pro-
moter regions. In the human gene exons 1 and 4 span ap-
proximately 28 kb and similarly an alternative promoter
may exist in this region to direct transcription of mRNA
isoforms that lack exon 1.
In addition to the transcriptional regulation of the
thioredoxin reductase 1 genes previously discussed, it is
also important to consider post-transcriptional control.
Recent studies [23,24] have investigated AU rich insta-
bility elements present in the 3' UT region of the human
TXNRD1 gene that facilitate mRNA degradation, leading
to rapid mRNA turnover. There are four AU elements
present in the human 3'UT region and three of these ele-
ments are also present in the 3' UT region of the mouse
Txnrd1 gene. Also, a non-AU rich instability element
present in the human TXNRD1 3'UT region [24] is 83%
conserved in the mouse Txnrd1 3'UT region [15] (Figure
5). Thus, control of thioredoxin reductase 1 mRNA levels
from both the human and mouse genomes appears to be
directed from elements present in both the 5' and 3' UT
regions.
Conclusions
In conclusion we report the genomic organisation of
mouse and human thioredoxin reductase 1 genes. These
genes display a conserved genomic organisation as the
coding regions of both genes have an almost identical
exon/intron structure. Comparison of mouse and human
5' sequences allows possible regulatory elements to be
identified and also in this study has enabled alternative
splicing events at the 5' end of each gene to be reviewed
Figure 4
Alignment of human thioredoxin reductase (TXNRD1) pro-
moter region with predicted mouse thioredoxin reductase
(Txnrd1) promoter region. Two potential AP-1 consensus
binding sites are outlined on Txnrd1 at positions 383 and 393.
The 5' end of Txnrd1 exon 1 is outlined at position 448.
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and further defined. Further work will be required to link
the different transcripts with specific promoter regulato-
ry elements.
Materials and methods
All chemicals were purchased from Sigma (Castle Hill,
NSW, Australia) unless otherwise indicated.
Genomic organisation of mouse Txnrd1 gene
• Cloning of mouse genomic Txnrd1 DNA
To obtain mouse genomic DNA clones for the determina-
tion of the genomic structure of the mouse Txnrd1 gene,
we initially screened a mouse genomic DNA library in λ
phage (Stratagene, La Jolla, CA, USA) with an α P32-
dATP labelled mouse Txnrd1 cDNA fragment as a probe.
Approximately 5 ×  105 plaques were prehybridised in
10% w/v dextran sulphate (Astral, Gymea, NSA, Austral-
ia), 2% w/v sodium dodecyl sulphate, 0.04% w/v bovine
serum albumin, 0.04% w/v polyvinyl pyrollidone (MW
40000), 0.04% w/v Ficoll and 1 M sodium chloride at 61
C for 4 hours. The probe was hybridised to the filters at
61 C for 12 hours. The filters were washed three times at
40 C in 2XSSC (0.3 M sodium chloride, 0.33 M sodium
citrate) and 0.1% w/v sodium dodecyl sulphate. Success-
ful screening of the mouse genomic DNA library pro-
duced two overlapping mouse Txnrd1 genomic clones
approximately 15 kb in length.
The Txnrd1 cDNA fragment used in the probe was gener-
ated using reverse transcriptase PCR that utilised mRNA
isolated from mouse liver tissue (Oligotex Direct mRNA
Mini Kit, Qiagen, Victoria, Australia) as the template
with oligonucleotides designed from the mouse Txnrd1
cDNA sequence [15]. These two oligonucleotides (for-
ward primer 5' ACATCTACGCCATTGGTGAC and re-
verse primer 5' TGGGGCTTAACCTCAGCAGC
(Geneworks, Adelaide, Australia)) amplified a region of
mouse Txnrd1 cDNA approximately 520 bp in length.
• Mapping of mouse Txnrd1
One of the clones obtained from the mouse genomic li-
brary screen was extensively mapped using restriction
enzyme digests and Southern blot analysis. The resulting
sequences were aligned with the mouse Txnrd1 cDNA se-
quence [15] using MacVector™ software (Oxford Molec-
ular Group) to reveal the intron/exon junctions for exons
5, 6, 9, 10, 11, 12, 13, 14 and 15.
To complete the intron/exon map of the mouse Txnrd1
gene, the mouse Txnrd1 cDNA sequence was used to
BLAST-search [25] the NCBI Trace Archive for mouse
genomic DNA fragments containing exons 1, 2, 3, 4, 7, 8
and 16. Numerous 1 kb genomic sequences were ob-
tained and aligned with the relevant exon sequences via
MacVector™ software to reveal the intron/exon junc-
tions.
Genomic organisation of the human TXNRD1 gene
The human TXNRD1 cDNA sequence [8] was used to
BLAST-search the NCBI human genome database for the
TXNRD1 genomic DNA sequence. The resulting genomic
sequence was aligned with the human TXNRD1 cDNA
sequence using MacVector™ software to reveal intron/
exon junctions.
Alternative splicing patterns
Mouse
BLAST-searches [25] of the NCBI EST and Trace Archive
databases were used to analyse the alternative splicing
patterns in the mouse Txnrd1 gene.
Human
BLAST-searches of the NCBI EST and human genome
databases were used to analyse the alternative splicing
patterns in the human TXNRD1 gene.
Promoter Elements
The human TXNRD1 promoter sequence was used to
BLAST-search the NCBI Trace Archive for the potential
mouse Txnrd1 promoter region.
Abbreviations
BLAST – Basic Local Alignment Search Tool
EST – Expressed Sequence Tags
GSSG – Oxidised Glutathione
NCBI – National Centre of Biotechnology Information
PCR – Polymerase Chain Reaction
Trx – Thioredoxin
Figure 5
Alignment of the non-AU rich instability element present in
the human TXNRD1 3'UT region with a sequence element
present in the mouse Txnrd1 3'UT region.
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